← 返回

EBV 驱动的胃肠道淋巴增殖性疾病和淋巴瘤:具有共同特征的一系列疾病(第 3 部分)

英文原题:EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3).

查看英文原题

EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3).

PubMed 2021/11/30(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

EB病毒(EBV)是首个已知参与多种肿瘤发生的致癌病毒。全球大多数人在生命早期感染EBV,病毒随后以潜伏状态终身存在,通常位于B淋巴细胞中。尽管EBV感染在全球广泛传播,只有少数人发生EBV相关疾病,且通常是在免疫抑制打破病毒感染与宿主免疫系统平衡时。EBV驱动的淋巴组织增生可来源于B细胞或T/NK细胞,疾病谱从惰性病变到侵袭性淋巴瘤不等。本综述分为三部分,更新胃肠道EBV相关淋巴系统疾病的认识;这些疾病常带来诊断和治疗挑战。本文旨在为日常临床实践中面对这一复杂疾病谱的临床医生和病理学家提供实用诊断方法。本部分讨论T细胞和NK细胞型慢性活动性EBV感染及其系统性形式、结外NK/T细胞淋巴瘤(鼻型)和移植后淋巴组织增生性疾病。

展开英文摘要原文

EBV is the first known oncogenic virus involved in the development of several tumors. The majority of the global population are infected with the virus early in life and the virus persists throughout life, in a latent stage, and usually within B lymphocytes. Despite the worldwide diffusion of EBV infection, EBV-associated diseases develop in only in a small subset of individuals often when conditions of immunosuppression disrupt the balance between the infection and host immune system.

EBV-driven lymphoid proliferations are either of B-cell or T/NK-cell origin, and range from disorders with an indolent behavior to aggressive lymphomas. In this review, which is divided in three parts, we provide an update of EBV-associated lymphoid disorders developing in the gastrointestinal tract, often representing a challenging diagnostic and therapeutic issue.

Our aim is to provide a practical diagnostic approach to clinicians and pathologists who face this complex spectrum of disorders in their daily practice. In this part of the review, the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders are discussed.

论文信息

作者
Zanelli M、Sanguedolce F、Palicelli A、Zizzo M、Martino G、Caprera C、Fragliasso V、Soriano A
第一作者单位
Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.Italy
通讯作者单位
Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy.Italy
文献类型
综述
期刊
Cancers2021 Nov 30
原文标识
PubMed 34885131 · DOI 10.3390/cancers13236021